Janoshik-verified per batch
Some patients may require blood tests before starting, while others may need repeated testing during treatment because of diabetes, kidney risk or other conditions
Informed Consent : Given that the treatment is not FDA- or CE-approved, it is important for patients to understand that large-scale clinical studies have not fully validated its safety and efficacy
GLP-1 and Blood Pressure: What the Evidence Shows GLP-1 receptor agonists, primarily licensed for type 2 diabetes and obesity management, have demonstrated modest blood pressure-lowering effects in clinical trials
Benefits Once-weekly injection Personalized dosing Dual GLP-1/GIP therapy Convenient weekly schedule Ideal for patients needing additional metabolic support Which One is Right for You
*Available for weight management patients Board-Certified Health Coaches Whether youre focused on reaching and maintaining a healthy weight, boosting energy levels, or enhancing your overall wellness, coaching provides a structured pathway tailored to your goals